http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5795980-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
filingDate 1980-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa29223188087f431fd9f445a813c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1216d44ad651531644e2ea82b190b5c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8f27821fb9224f44007b56410c4f427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b45e663ab3ee9bb0604b862f44baa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3e031c2c78c88ee6aed81c1b9b7b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a003e516b0070f4851f6e5ac45810acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c247b3bab7eff298cd96066158853b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cc131ed8a82d49cd5d79f8e408787e
publicationDate 1982-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5795980-A
titleOfInvention 7-hydroxy pgi2 and its preparation
abstract NEW MATERIAL:A 7-hydroxy PGI 2 shown by the formula I(R 1 is H, or 1W10C alkyl; K 2 and R 3 are H or OH-protecting group) or its acid addition salt where R 1 is H. n EXAMPLE: 7-Hydroxyl-PGI 2 methyl ester 11, 15-bis t-butyldimethyl-silyl ether. n USE: A hypotensor and an inhibitor for blood platelet aggregation, having improved stability and action selectivity as a drug of PGI 2 . n PROCESS: A compound shown by the formula II(R" is 1W10C alkyl) wherein preferably a steric configuration of 5-position is (R)-configuration, Δ 6 -double bond is (Z)-configuration, and a steric configuration of 7-position is (S) configuration is treated with a sulfurphilic compound, preferably an amine or a phosphorous type compound, and, if necessary, the resulting compound is subjected to a protective group removing reaction, a salt-forming reaction and/or a protecting reaction, to give a compound shown by the formulaIor a pharmaceutically acceptable salt of its acid. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112979600-A
priorityDate 1980-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID590018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416027229

Total number of triples: 28.